CEACAM1 and the regulation of mucosal inflammation

Mucosal Immunology

Volumn 1, Issue , 2008, Pages 39-42

  Nagaishi, T ^a   Chen, Z ^a   Chen, L ^a   Iijima, H ^a   Nakajima, A ^a   Blumberg, R S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CYTOKINE;

CYTOKINE PRODUCTION; DRUG TARGETING; ENTERITIS; HUMAN; LYMPHOCYTE FUNCTION; MEDIATOR RELEASE; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD; CELL ADHESION MOLECULES; GENE EXPRESSION REGULATION; HUMANS; MUCOSITIS; T-LYMPHOCYTES;

EID: 54349124617     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2008.50     Document Type: Review

References (21)

1. Strober, W., Fuss, I. J. & Blumberg, R. S. The immunology of mucosal models of inflammation. Ann. Rev. Immunol. 20, 495-549 (2002).
2. Xavier, R. J. & Podolsky, D. K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434 (2007).
3. Zheng, Y. & Rudensky, A. Y. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8, 457-462 (2007).
4. Mucida, D. et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256-260 (2007).
5. Collison, L. W. et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566-569 (2007).
6. Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S. & Bhan, A. K. Chronic intestinal inflammatory condition generates IL-10 producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16, 219-230 (2002).
7. Brimnes, J., Allez, M., Dotan, I., Shao, L., Nakazawa, A. & Mayer, L. Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J. Immunol. 174, 5814-5822 (2005).
8. Kunos, G. & Pacher, P. Cannabinoids cool the intestine. Nat. Med. 10, 678-679 (2004).
9. Phillipe, D. et al. Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon cancer. J. Clin. Invest. 111, 1329-1338 (2003).
10. Arita, M. et al. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. USA 102, 7671-7676 (2005).
11. Fiorucci, S. et al. A beta-oxidation-resistant A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction. Proc. Natl. Acad. Sci. USA 101, 15736-15741 (2004).
12. Vonwinkel, T. et al. Apolipoprotein A-IV inhibits experimental colitis. J. Clin. Invest. 114, 260-269 (2004).
13. Greenwald, R. J., Freeman, G. J. & Sharpe, A. The B7 family revisited. Annu. Rev. Immunol. 23, 515-548 (2005).
14. Owen, G. S. & Blumberg, R. S. Carcinoembryonic cell adhesion molecule 1 in immune regulation. Nat. Rev. Immunol. 6, 433-446 (2006).
15. Dveksler, G. S. et al. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus A-59. J. Virol. 67, 108 (1993).
16. Markel, G. et al. Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions. J. Clin. Invest. 110, 943-953 (2002).
17. Morales, V. et al. Regulation of human intestinal intraepithelial lymphocyte cytolytic function by biliary glycoprotein (CD66a). J. Immunol. 163, 1363-1370 (1999).
18. Nakajima, A. et al. Activation-induced expression of carcinoembryonic antigen-cell adhesion molecule 1 regulates mouse T lymphocyte function. J. Immunol. 168, 1028-1035 (2002).
19. Chen, D. et al. Carcinoembryonic antigen-related cellular adhesion molecule 1 isoforms alternatively inhibit and costimulate human T cell function. J. Immunol. 172, 3535-3543 (2004).
20. Iijima, H. et al. Specific regulation of T helper 1-mediated murine colitis by CEACAM1. J. Exp. Med. 199, 471-482 (2004).
21. Nagaishi, T. et al. SHP1 Phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity 25, 1-13 (2006).